During its Nanopore Community Meeting, held online this year, the firm announced several product releases, technology improvements, and development projects.
The company, which raised about $1.6 million earlier this year, said it will use the new funding to accelerate development of its 3D sequencing platform.
A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.
